AR067382A1 - Soluciones oftalmicas estabilizadas - Google Patents

Soluciones oftalmicas estabilizadas

Info

Publication number
AR067382A1
AR067382A1 ARP080102836A ARP080102836A AR067382A1 AR 067382 A1 AR067382 A1 AR 067382A1 AR P080102836 A ARP080102836 A AR P080102836A AR P080102836 A ARP080102836 A AR P080102836A AR 067382 A1 AR067382 A1 AR 067382A1
Authority
AR
Argentina
Prior art keywords
pentaacetic acid
diethylenetriamin
ppm
ophthalmic solutions
peroxide
Prior art date
Application number
ARP080102836A
Other languages
English (en)
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of AR067382A1 publication Critical patent/AR067382A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Soluciones oftálmicas estabilizadas que comprenden por lo menos un peroxido. En una forma de realizacion, la presente se refiere a una solucion oftálmica que comprende un pH entre alrededor de 6 y alrededor de 8 y desde alrededor de 50 hasta alrededor de 1000 ppm de peroxido de hidrogeno y desde alrededor de 0,005 % en peso (50 ppm) hasta alrededor de 0,05 % en peso (500 ppm) de por lo menos una sal del ácido dietilentriamin pentaacético seleccionada entre el grupo integrado por sales de calcio del ácido dietilentriamin pentaacético, sales de zinc del ácido dietilentriamin pentaacético y sales mixtas de calcio / zinc del ácido dietilentriamin pentaacético. La presente además se refiere a un método para conservar una solucion oftálmica que comprende por lo menos un peroxido.
ARP080102836A 2007-06-29 2008-06-30 Soluciones oftalmicas estabilizadas AR067382A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94718407P 2007-06-29 2007-06-29
US12/124,882 US20090004288A1 (en) 2007-06-29 2008-05-21 Stabilized ophthalmic solutions

Publications (1)

Publication Number Publication Date
AR067382A1 true AR067382A1 (es) 2009-10-07

Family

ID=40160848

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102836A AR067382A1 (es) 2007-06-29 2008-06-30 Soluciones oftalmicas estabilizadas

Country Status (12)

Country Link
US (1) US20090004288A1 (es)
EP (1) EP2167106A1 (es)
JP (1) JP2010532349A (es)
KR (1) KR20100088123A (es)
CN (1) CN101808652A (es)
AR (1) AR067382A1 (es)
AU (1) AU2008271225A1 (es)
BR (1) BRPI0813959A2 (es)
CA (1) CA2692227A1 (es)
RU (1) RU2010102904A (es)
TW (1) TW200916108A (es)
WO (1) WO2009005601A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090239775A1 (en) * 2008-03-19 2009-09-24 Collins Gary L Ophthalmic solutions displaying improved efficacy
US20100226999A1 (en) * 2009-03-06 2010-09-09 Tracy Quevillon-Coleman Process for forming stabilized ophthalmic solutions
WO2017081613A1 (en) * 2015-11-09 2017-05-18 Yte International Inc. Composition for treating contact lenses with an aqueous solution resulting in visible protein removal

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3701825A (en) * 1970-10-23 1972-10-31 Fmc Corp Stabilization of hydrogen peroxide with ethylenediamine tetra (methylenephosphonic acid)
NL7608266A (nl) * 1975-08-16 1977-02-18 Henkel & Cie Gmbh Concentraten van microbicide middelen.
US4304762A (en) * 1978-09-27 1981-12-08 Lever Brothers Company Stabilization of hydrogen peroxide
US4347149A (en) * 1980-04-01 1982-08-31 Interox Chemicals Limited Aqueous bleach compositions
DE3307315A1 (de) * 1983-03-02 1984-09-06 Krupp-Koppers Gmbh, 4300 Essen Verfahren zur reinigung von chemiegips
US4614646A (en) * 1984-12-24 1986-09-30 The Dow Chemical Company Stabilization of peroxide systems in the presence of alkaline earth metal ions
US4889689A (en) * 1986-10-14 1989-12-26 Ciba-Geigy Corporation Method of disinfecting a soft contact lens with a diethylene triamine penta(methylenephosphonic acid) stabilized hydrogen peroxide solution
US4812173A (en) * 1987-05-01 1989-03-14 Ciba-Geigy Corporation Stabilized hydrogen peroxide contact lens disinfecting solution
US5607698A (en) * 1988-08-04 1997-03-04 Ciba-Geigy Corporation Method of preserving ophthalmic solution and compositions therefor
US5300296A (en) * 1989-11-06 1994-04-05 Frank J. Holly Antimicrobial agent for opthalmic formulations
US5171526A (en) * 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
US5277901A (en) * 1990-01-05 1994-01-11 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
US5451398A (en) * 1990-01-05 1995-09-19 Allergan, Inc. Ophthalmic and disinfecting compositions and methods for preserving and using same
US5145643A (en) * 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
US5356555A (en) * 1992-09-14 1994-10-18 Allergan, Inc. Non-oxidative method and composition for simultaneously cleaning and disinfecting contact lenses using a protease with a disinfectant
US5514732A (en) * 1993-07-22 1996-05-07 Johnson & Johnson Vision Products, Inc. Anti-bacterial, insoluble, metal-chelating polymers
US6024954A (en) * 1994-12-12 2000-02-15 Allergan Compositions and methods for disinfecting contact lenses and preserving contact lens care products
US5776028A (en) * 1995-09-01 1998-07-07 Honda Giken Kogyo Kabushiki Kaisha Belt-type continuously variable transmission
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US20070104798A1 (en) * 1999-10-04 2007-05-10 S.K. Pharmaceuticals, Inc. Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
US20040037891A1 (en) * 1999-10-04 2004-02-26 Karagoezian Hampar L. Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
TWI236377B (en) * 2000-09-28 2005-07-21 Novartis Ag Stabilized hydrogen peroxide solutions
US20070110782A1 (en) * 2000-11-08 2007-05-17 Fxs Ventures, Llc L-histidine in ophthalmic solutions
US20050277584A1 (en) * 2004-06-09 2005-12-15 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins

Also Published As

Publication number Publication date
KR20100088123A (ko) 2010-08-06
RU2010102904A (ru) 2011-08-10
CN101808652A (zh) 2010-08-18
BRPI0813959A2 (pt) 2015-07-14
CA2692227A1 (en) 2009-01-08
WO2009005601A1 (en) 2009-01-08
US20090004288A1 (en) 2009-01-01
EP2167106A1 (en) 2010-03-31
TW200916108A (en) 2009-04-16
AU2008271225A1 (en) 2009-01-08
JP2010532349A (ja) 2010-10-07

Similar Documents

Publication Publication Date Title
AR087720A1 (es) Proceso de remineralizacion de agua desalinizada y dulce dosificando una solucion de carbonato de calcio en agua blanda
ES2537539T3 (es) Composición oftálmica
CO7131390A2 (es) Espuma o composición con viscosidad mejorada que contiene un agente quelante
UY29526A1 (es) Amidas de rcido pirazolcarboxelico
ECSP10010367A (es) Método para el tratamiento de una sola etapa de formaciones subterráneas de sílice
AR081060A1 (es) Procedimiento para preparar 4-{4-[({[4-cloro-3-(trifluorometil)fenil]amino}carbonil)amino]-3-fluorofenoxi}-n-metilpiridin-2-carboxamida
UY31751A (es) Composiciones que tienen actividad biocida para preparaciones acuosas
GT201200196A (es) Método para realizar una composición antitranspirante anhidra líquida
EA201491771A1 (ru) Офтальмологический раствор, содержащий диквафасол
SV2009003349A (es) Compuestos triciclicos, composiciones y procedimientos
AR065963A1 (es) Solucion acuosa de peroxido de hidrogeno, proceso para su preparacion y su uso
AR087217A1 (es) Sistema de inyeccion de una suspension de cacomicronizada para la remineralizacion del agua desalinizada y dulce
CL2015001151A1 (es) Composición de hipoclorito de sodio y método de almacenamiento y transporte de hipoclorito de sodio.
AR055761A1 (es) Procedimiento para preparar especies de aluminio
BR112015013430A2 (pt) método de aprimoramento da compatibilidade de uma solução herbicida aquosa; solução herbicida aquosa com compatibilidade aprimorada; e composição herbicida secante
MY171414A (en) Compositions and methods for improving the compatibility of water soluble herbicide salts
GB2500128A (en) Colonoscopy-preparation
AR095681A2 (es) Una solución acuosa desinfectante no terapéutica, un método para prepararla, una preparación desinfectante y un método para desinfectar o esterilizar un objeto
MX2009007265A (es) Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion.
MX2015016424A (es) Soluciones acuosas que contienen un agente complejante de alto grado de concentracion.
CL2011000025A1 (es) Una sal o mezcla de sales de acido (s)(+)-abscisico, seleccionada del grupo que consiste de sal de rubidio, sal de tetrametilamonio, sal de tetrapropilamonio, sal de tetrabutilamonio, sal de colina, sal de dimetilpiperidinio y sal cloroetiltrimetilamonio, una sal de guanidinio o mezcla de sales de guanidinio de ácido (s)-(+)-absicico, una mezcla de sales de ácido (s)-(+)-abcisico, y una composicion acuosa para el tratamiento de plantas.
ES2673406T3 (es) Alfa-derivados de ácidos grasos cis-monoinsaturados para uso como medicamentos en el tratamiento de la diabetes
PE20150278A1 (es) Agentes de aclareo que contienen diuron
AR067382A1 (es) Soluciones oftalmicas estabilizadas
AR075097A1 (es) Sales y formas polimorficas cristalinas de [4-(6-fluoro-7-metilamino-2,4-dioxo-1,4-dihidro-2h-quinazolin-3-il)-fenil]-5-cloro-tiofen-2-il-sulfonil urea, composiciones farmaceuticas que las contiene, metodo para prepararlas y uso de las mismas en el tratamiento de enfermedades cardiovasculares asocia

Legal Events

Date Code Title Description
FA Abandonment or withdrawal